Showing results (671-680 of 6,487) with videos related to
Sort By:
Pageof 649
Journal of Thrombosis and Haemostasis : JTH|November 23, 2007
A highly-sensitive plasma von Willebrand factor ristocetin cofactor (VWF:RCo) activity assay by flow cytometryD Chen, C A Daigh, J I Hendricksen, et al.Journal of Thrombosis and Haemostasis : JTH|October 1, 2008
Reduced factor VII and factor VIII levels and prolonged thrombin-generation times during a healthy diet in middle-aged women with mild to moderate cardiovascular disease riskA Passaro, S Calzavarini, S Volpato, et al.Journal of Thrombosis and Haemostasis : JTH|August 6, 2008
Pharmacodynamic resistance to warfarin is associated with nucleotide substitutions in VKORC1D J Harrington, R Gorska, R Wheeler, et al.Journal of Thrombosis and Haemostasis : JTH|October 2, 2008
Mitogen-activated protein kinases in hemostasis and thrombosisF Adam, A Kauskot, J-P Rosa, et al.Journal of Thrombosis and Haemostasis : JTH|October 2, 2008
Collagen-mimetic peptides mediate flow-dependent thrombus formation by high- or low-affinity binding of integrin alpha2beta1 and glycoprotein VII C A Munnix, K Gilio, P R M Siljander, et al.Journal of Thrombosis and Haemostasis : JTH|October 2, 2008
Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cellsM Qadura, M Othman, B Waters, et al.Journal of Thrombosis and Haemostasis : JTH|October 15, 2008
Warfarin for atrial fibrillation in community-based practiseA J Rose, A Ozonoff, L E Henault, et al.Journal of Thrombosis and Haemostasis : JTH|July 8, 2008
Effects of apoptosis and lipid peroxidation on T-lymphoblastoid phospholipid-dependent procoagulant activityW Pickering, E Gray, A H Goodall, et al.Journal of Thrombosis and Haemostasis : JTH|July 16, 2008
A snake venom metalloproteinase, kistomin, cleaves platelet glycoprotein VI and impairs platelet functionsC C Hsu, W B Wu, T F HuangJournal of Thrombosis and Haemostasis : JTH|July 16, 2008
DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profilesT Furugohri, K Isobe, Y Honda, et al.Pageof 649